These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23227575)

  • 1. lennox-Gastaut syndrome: an updateon treatment.
    Carmant L; Whiting S
    Can J Neurol Sci; 2012 Nov; 39(6):702-11. PubMed ID: 23227575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of Lennox-Gastaut syndrome.
    VanStraten AF; Ng YT
    Pediatr Neurol; 2012 Sep; 47(3):153-61. PubMed ID: 22883278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.
    Gresham J; Eiland LS; Chung AM
    Neuropsychiatr Dis Treat; 2010 Oct; 6():639-45. PubMed ID: 20957124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
    Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
    Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lennox-Gastaut syndrome--course and treatment].
    Lund C; Brodtkorb E; Nakken KO
    Tidsskr Nor Laegeforen; 2011 Jan; 131(1):24-7. PubMed ID: 21233883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
    Lee EH; Yum MS; Ko TS
    Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.
    Arzimanoglou A; Pringsheim M; Kluger GJ; Genton P; Perdomo C; Malhotra M
    Epilepsy Behav; 2021 Sep; 124():108275. PubMed ID: 34509883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at onset in patients with Lennox-Gastaut syndrome: Correlations with clinical manifestations.
    Asadi-Pooya AA; Farazdaghi M
    J Clin Neurosci; 2022 Jun; 100():138-142. PubMed ID: 35468350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile spasms and Lennox-Gastaut syndrome.
    Trevathan E
    J Child Neurol; 2002 Feb; 17 Suppl 2():2S9-2S22. PubMed ID: 11952036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
    Kim SH; Eun SH; Kang HC; Kwon EJ; Byeon JH; Lee YM; Lee JS; Eun BL; Kim HD
    Seizure; 2012 May; 21(4):288-91. PubMed ID: 22421185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
    Kim SH; Kang HC; Lee JS; Kim HD
    Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational approach to treatment options for Lennox-Gastaut syndrome.
    Montouris GD
    Epilepsia; 2011 Aug; 52 Suppl 5():10-20. PubMed ID: 21790561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.